Multidrug-resistant Typhoid Fever

Overview

Journal Indian J Pediatr

Specialty Pediatrics

Date 2007 Feb 1

PMID 17264451

Citations 12

Authors

Rajiv Kumar

Nomeeta Gupta

Affiliations

Soon will be listed here.

Abstract

Objective: To study the epidemiological pattern, clinical picture, the recent trends of multidrug-resistant typhoid fever (MDRTF), and therapeutic response of ofloxacin and ceftriaxone in MDRTF.

Methods: The present prospective randomized controlled parallel study was conducted on 93 blood culture-proven Salmonella typhi children. All MDRTF cases were randomized to treatment with ofloxacin or ceftriaxone.

Results: Of 93 children, 62 (66.6%) were MDRTF. 24 cases were below 5 years, 26 between 5-10 years and 12 were above 10 years. Male to female ratio was 1.85: 1. Majority of cases came from lower middle socio-economic classes with poor personal hygiene. Fever was the main presenting symptom. Hepatomegaly and splenomegaly was present in 88% and 46% cases respectively. 19 (30.6%) cases developed complications. Mean defervescence time with ceftriaxone and ofloxacin was 4.258 and 4.968 days respectively.

Conclusion: MDRTF is still emerging as serious public and therapeutic challenge. Ceftriaxone is well-tolerated and effective drug but expensive whereas ofloxacin is safe, cost-effective and therapeutic alternative in treatment of MDRTF in children with comparable efficacy to ceftriaxone.

Citing Articles

Knowledge, attitudes, and practices regarding antibiotic use in Bangladesh: Findings from a cross-sectional study.

Raihan M, Islam M, Islam S, Mahmudul Islam A, Ahmed K, Ahmed T PLoS One. 2024; 19(2):e0297653.

PMID: 38346032 PMC: 10861050. DOI: 10.1371/journal.pone.0297653.

Treatment of enteric fever (typhoid and paratyphoid fever) with cephalosporins.

Kuehn R, Stoesser N, Eyre D, Darton T, Basnyat B, Parry C Cochrane Database Syst Rev. 2022; 11:CD010452.

PMID: 36420914 PMC: 9686137. DOI: 10.1002/14651858.CD010452.pub2.

Response of extensively drug resistant Salmonella Typhi to treatment with meropenem and azithromycin, in Pakistan.

Qureshi S, Naveed A, Yousafzai M, Ahmad K, Ansari S, Lohana H PLoS Negl Trop Dis. 2020; 14(10):e0008682.

PMID: 33057330 PMC: 7561124. DOI: 10.1371/journal.pntd.0008682.

Drug utilization, rationality, and cost analysis of antimicrobial medicines in a tertiary care teaching hospital of Northern India: A prospective, observational study.

Bimba H, Roy V, Batta A, Daga M Indian J Pharmacol. 2020; 52(3):179-188.

PMID: 32874000 PMC: 7446674. DOI: 10.4103/ijp.IJP_225_19.

High Burden of Antimicrobial Resistance and Mortality Among Adults and Children With Community-Onset Bacterial Infections in India.

Mave V, Chandanwale A, Kagal A, Khadse S, Kadam D, Bharadwaj R J Infect Dis. 2017; 215(8):1312-1320.

PMID: 28329303 PMC: 5853545. DOI: 10.1093/infdis/jix114.

References

Biswal N, Mathai B, Bhatia B, Srinivasan S, Nalini P . Enteric fever: a changing perspective. Indian Pediatr. 1994; 31(7):813-9. View

Vallenas C, Hernandez H, Kay B, Black R, Gotuzzo E . Efficacy of bone marrow, blood, stool and duodenal contents cultures for bacteriologic confirmation of typhoid fever in children. Pediatr Infect Dis. 1985; 4(5):496-8. DOI: 10.1097/00006454-198509000-00011. View

Kabra S, Madhulika , Talati A, Soni N, Patel S, Modi R . Multidrug-resistant typhoid fever. Trop Doct. 2000; 30(4):195-7. DOI: 10.1177/004947550003000404. View

Smith M, Duong N, Hoa N, Wain J, Ha H, Diep T . Comparison of ofloxacin and ceftriaxone for short-course treatment of enteric fever. Antimicrob Agents Chemother. 1994; 38(8):1716-20. PMC: 284627. DOI: 10.1128/AAC.38.8.1716. View

Sinha A, Sazawal S, Kumar R, Sood S, Reddaiah V, Singh B . Typhoid fever in children aged less than 5 years. Lancet. 1999; 354(9180):734-7. DOI: 10.1016/S0140-6736(98)09001-1. View

Ramsey B . Management of pulmonary disease in patients with cystic fibrosis. N Engl J Med. 1996; 335(3):179-88. DOI: 10.1056/NEJM199607183350307. View

Ramachandran S, Godfrey J, Perera M . Typhoid hepatitis. JAMA. 1974; 230(2):236-40. View

Rasaily R, Dutta P, Saha M, Mitra U, Lahiri M, Pal S . Multi-drug resistant typhoid fever in hospitalised children. Clinical, bacteriological and epidemiological profiles. Eur J Epidemiol. 1994; 10(1):41-6. DOI: 10.1007/BF01717450. View

Chandra R, Srinivasan S, Nalini P, Rao R . Multidrug resistant enteric fever. J Trop Med Hyg. 1992; 95(4):284-7. View

10.

Wasfy M, Oyofo B, David J, Ismail T, El-Gendy A, Mohran Z . Isolation and antibiotic susceptibility of Salmonella, Shigella, and Campylobacter from acute enteric infections in Egypt. J Health Popul Nutr. 2000; 18(1):33-8. View

11.

Ivanoff B, Levine M, Lambert P . Vaccination against typhoid fever: present status. Bull World Health Organ. 1994; 72(6):957-71. PMC: 2486740. View

12.

Wongsawat J, Pancharoen C, Thisyakorn U . Typhoid fever in children: experience in King Chulalongkorn Memorial Hospital. J Med Assoc Thai. 2003; 85(12):1247-50. View

13.

Bhutta Z, Naqvi S, Razzaq R, Farooqui B . Multidrug-resistant typhoid in children: presentation and clinical features. Rev Infect Dis. 1991; 13(5):832-6. DOI: 10.1093/clinids/13.5.832. View

14.

Sood S, Kapil A, Das B, Jain Y, Kabra S . Re-emergence of chloramphenicol-sensitive Salmonella typhi. Lancet. 1999; 353(9160):1241-2. DOI: 10.1016/s0140-6736(99)00637-6. View

15.

Garg K, Mangal N, Mathur H . Clinical profile of multi drug resistant typhoid fever in Jaipur City. Indian Pediatr. 1994; 31(2):191-3. View

16.

Agarwal K, Singh S, Kumar N, Srivastav R, Rajkumar A . A study of current trends in enteric fever. J Commun Dis. 1999; 30(3):171-4. View

17.

Asperilla M, Smego Jr R, Scott L . Quinolone antibiotics in the treatment of Salmonella infections. Rev Infect Dis. 1990; 12(5):873-89. DOI: 10.1093/clinids/12.5.873. View

18.

Koul P, Murali M, Sharma P, GHAI O, Ramchandran V, Talwar V . Multi drug resistant Salmonella typhi infection: clinical profile and therapy. Indian Pediatr. 1991; 28(4):357-61. View

19.

Johnson A, Aderele W . Enteric fever in childhood. J Trop Med Hyg. 1981; 84(1):29-35. View